Genenta Science enters binding offer to fund Sophia High Tech

Genenta Science (GNTA) announced that it has entered into a binding offer with Sophia High Tech, under which Genenta will fund Sophia through two reserved capital increases, with the goal of reaching a controlling stake upon the achievement of defined performance milestones. The transaction with Sophia High Tech would be completed in two phases and remains subject to confirmatory due diligence, required approvals, and definitive transaction documentation. Sophia High Tech is an aerospace and defense engineering and manufacturing company, headquartered in Somma Vesuviana, Italy. Genenta expects to fund a total of EUR 6M in two tranches, the second tranche being performance-driven. Sophia High Tech is projecting growing revenues. Sophia HT is already profitable and forecasts continued EBITDA growth in 2026, 2027 and beyond. The funds are expected to be used for materially scaling production capacity, accelerating technological differentiation, and strengthening commercial penetration.